Can-Fite BioPharma CANF
NYSE CANF
$1.85 -0.04 (-2.12%)
At close: Oct 22, 2026 · 4:00 PM EDT

Can-Fite BioPharma (CANF) Free Cash Flow (2012 - 2013)

Updated

Can-Fite BioPharma (CANF) reported Free Cash Flow of -$8.95 million for FY2025, compared with -$7.63 million in FY2024.

Analysis

Can-Fite BioPharma (CANF) Free Cash Flow (2012 - 2013) Analysis & Trends

Dating back to FY2015, Can-Fite BioPharma's Free Cash Flow record includes 11 years.

  • The FY2025 figure ranks as the lowest annual Free Cash Flow since FY2022.
  • According to Business Quant data, Free Cash Flow came in at -$7.63 million in FY2024, -$8.44 million in FY2023, -$10.79 million in FY2022 and -$9.85 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF (Qtr)
1 Eli Lilly 1,139.85 Bn 1,108.44 Bn 19.71 Bn 7.76 Bn
2 Johnson & Johnson 634.68 Bn 554.54 Bn 17.30 Bn 6.36 Bn
3 AbbVie 500.89 Bn 474.00 Bn 12.70 Bn 3.11 Bn
4 Merck 354.57 Bn 308.95 Bn 12.21 Bn 4.48 Bn
5 Novartis Ag 300.14 Bn 264.13 Bn 11.24 Bn 5.56 Bn
6 Astrazeneca 263.08 Bn 236.77 Bn 12.86 Bn 1.01 Bn
7 Amgen 237.91 Bn 193.31 Bn 7.24 Bn 3.49 Bn
8 Gilead Sciences 193.96 Bn 168.15 Bn 6.22 Bn 3.43 Bn
9 Pfizer 170.07 Bn 116.71 Bn 10.94 Bn 302.00 Mn
10 Can-Fite BioPharma 1.51 Mn -18.20 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 -3.20 Mn
Sep 30, 2013 -1.39 Mn
Jun 30, 2013 -2.50 Mn
Dec 31, 2012 -2.76 Mn
Sep 30, 2012 -381,325.47
Jun 30, 2012 -1.43 Mn
API Access

Can-Fite BioPharma Free Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=free-cash-flow&ticker=CANF&period=max&api_key=YOUR_API_KEY